Słomko, Joanna, Estévez-López, Fernando, Kujawski, Sławomir et al. · Journal of clinical medicine · 2020 · DOI
This study looked at 131 ME/CFS patients to see if different types of autonomic nervous system problems (the system that controls heart rate, blood pressure, and digestion) exist. Researchers found four distinct patterns: some patients had sympathetic overactivity with dysfunction, some had sympathetic symptoms alone, some had parasympathetic issues, and some had an imbalance between the two systems. Patients with sympathetic overactivity had the most severe symptoms and worst quality of life, while those with balanced autonomic function were younger, less fatigued, and reported better quality of life.
This study provides evidence that ME/CFS patients have distinct autonomic nervous system profiles that correlate with disease severity and quality of life, suggesting that one-size-fits-all treatment approaches may be insufficient. Identifying these autonomic phenotypes could enable personalized, profile-specific interventions and help clinicians better understand which patients are at highest risk for severe disease.
This study does not establish that autonomic phenotypes cause ME/CFS severity or that correcting autonomic dysfunction will improve outcomes; it only shows correlation. The cross-sectional design cannot determine whether autonomic dysregulation develops early in illness or emerges as a consequence of prolonged ME/CFS. The study lacks healthy control and ME/CFS disease controls, so it cannot confirm these phenotypes are unique to ME/CFS or that the differences are clinically meaningful rather than normal variation.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →